Public Companies
Senate hemp bill aims to loosen restrictions (Newsletter: March 27, 2023)
MD legal sales vote; OR interstate marijuana commerce suit; NV psychedelics; Canada dispensary study; Congressman: protect patients from pesticides Subscribe to…
MD legal sales vote; OR interstate marijuana commerce suit; NV psychedelics; Canada dispensary study; Congressman: protect patients from pesticides
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen.
If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
Sens. Jon Tester (D-MT) and Mike Braun (R-IN) filed a new bipartisan bill to ease testing and sampling requirements on industrial hemp producers who grow the crop for purposes other than cannabinoid extraction.
Rep. Scott Peters (D-CA) argued at a House Natural Resources Federal Lands Subcommittee hearing that his bill to combat the use of banned pesticides at illegal marijuana grow sites will protect the health of consumers—especially medical cannabis patients.
Maryland’s Senate president said the chamber will vote on a bill to regulate marijuana sales this week. Meanwhile, regulators released new reports to help the state prepare for legalization’s launch.
The Nevada Senate Health and Human Services Committee held a hearing on a bill to legalize psilocybin—hearing testimony from many advocates, including an Assembly lawmaker who described his own experiences with psychedelic therapy.
An Oregon marijuana business challenging the state’s ban on interstate cannabis commerce is asking a federal judge to allow its lawsuit to be heard in court and reject state officials’ motion to dismiss the case.
A new study of Canada’s legal marijuana industry found that “59% of neighbourhoods were within a 5-minute drive of a cannabis store” and that the market has “expanded enormously over the first 4 years” following legalization.
South Dakota Gov. Kristi Noem (R) vetoed a bill that would have allowed hemp products in process to have up to 5 percent THC.
The Montana Senate Business, Labor and Economic Affairs Committee rejected House-passed bills to ban most marijuana advertising and require warning labels for pregnant women on cannabis products.
Virginia lawmakers are considering amending a hemp product restriction bill to accommodate the concerns of patients who say it may impede their access to CBD medicines.
/ FEDERAL
The Drug Enforcement Administration released a report with recommendations on improving the effectiveness and integrity of the agency’s foreign operations.
A U.S. Air Force official spoke about the branch’s marijuana enlistment waiver program during testimony at a Senate hearing.
A new resolution from Sen. Sherrod Brown (D-OH) commemorating National Poison Prevention Week notes the issue of accidental edible cannabis ingestion.
/ STATES
Kentucky Gov. Andy Beshear (D) signed a bill to regulate delta-8 THC products. Separately, he signed an emergency regulation banning the sale of products containing tianeptine.
Colorado Gov. Jared Polis (D) signed a bill allowing regulators to embargo and destroy marijuana if “health, safety, or welfare of the public imperatively requires emergency action.” Separately, the Senate confirmed the governor’s nominations to serve on the Natural Medicine Advisory Board.
South Dakota Gov. Kristi Noem (R) signed legislation to add new medical cannabis qualifying conditions, prohibit doctors from issuing recommendations to pregnant and breastfeeding women and restrict them from having certain financial relationships with medical marijuana businesses.
Missouri Republican gubernatorial candidate Bill Eigel, currently a state senator, spoke about his opposition to marijuana legalization.
The Oklahoma Senate passed a number of bills amending medical cannabis rules.
North Carolina senators filed a bill to ban delta-8 and delta-9 THC products from schools and school-sponsored events.
A South Carolina senator expressed frustration in a Senate floor speech about his medical cannabis legislation being blocked from consideration.
A California senator tweeted, “Our bill to decriminalize possession & use of psychedelics (SB 58) passed the Senate Public Safety Committee. It’s time for CA to move away from criminalizing these substances, which are not addictive & which have so much potential for mental health & substance use treatment.”
Minnesota representatives discussed a bill to create a psychedelics task force.
A Pennsylvania senator said he’s “not a big fan of” the idea of putting marijuana sales in state-run stores.
New York regulators adopted rules on marijuana packaging, labeling, marketing, advertising and laboratories.
Washington State regulators are considering extending the application deadline for social equity cannabis retail licenses.
Vermont regulators updated the list of cannabis products registered for sale.
Oregon regulators posted a series of forms that people must fill out before receiving psilocybin services.
—
Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
The St. Louis County, Missouri Council is considering enacting a ban on smoking marijuana at county parks.
/ INTERNATIONAL
Toronto, Ontario, Canada’s government expanded its drug decriminalization proposal to cover young people in addition to adults, as well as all drugs.
The leader of the Irish Labour Party said the government should license the sale of cannabis at music festivals.
A Bogota, Colombia economic development official participated in a cannabis event.
/ SCIENCE & HEALTH
A review concluded that “oral fluid tests showed the most promise for use in roadside screening for blood THC levels over legal limits,…urine tests are generally inadvisable, and observational tests require sensitivity improvements.”
/ ADVOCACY, OPINION & ANALYSIS
A poll of Britons found that 55 percent said they could definitely identify the smell of cannabis.
A poll of Philadelphia, Pennsylvania residents found that 22 percent support arresting drug users and 27 back allowing safe consumption sites for illegal drugs.
RTI International is holding an event on cannabis equity on Thursday.
/ BUSINESS
atai Life Sciences reported a quarterly net loss of $45 million.
Altria Group Inc.’s CEO said the company is considering expanding into cannabis products.
Aurora Cannabis Inc. received notification that it is not in compliance with Nasdaq’s minimum bid price requirements.
Curaleaf Holdings, Inc. is delaying its earnings call scheduled for Tuesday.
Ascend Wellness Holdings LLC is being sued by a former employee who says he was improperly fired after being incorrectly blamed for theft.
MedMen Enterprises Inc. changed its auditor.
Canadian retailers sold C$395.5 million worth of legal cannabis products in January.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Photo courtesy of Chris Wallis // Side Pocket Images.
The post Senate hemp bill aims to loosen restrictions (Newsletter: March 27, 2023) appeared first on Marijuana Moment.
psychedelics psychedelic psilocybin atai atai life sciences-
Psychedelics1 week ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Psychedelics1 week ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Law & Regulation1 week ago
Tryp Therapeutics merger with Exopharm approved by shareholders
-
Psilocybin1 week ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics1 week ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
-
Psilocybin1 week ago
Psilocybin and Meditation: Unlocking the Potential for Enhancing Insightfulness
-
Psychedelics1 week ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID